Hangzhou Jianjia Robot Co., Ltd. announced that it has received $31 million in funding from Lyfe Capital, SB China Venture Capital, Hillhouse Capital Management, Ltd., Shanghai Fosun Pharmaceutical Co., Ltd.
Hangzhou Jianjia Robot Co., Ltd announced that it has received $31,000,000 in a round of funding led by Lyfe Capital on May 20, 2021. The transaction included participation from SB China Venture Capital and returning investors GL Ventures a fund managed by Hillhouse Capital Management, Ltd. and Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SHSE:600196).